Long-term Effects of AAT in Patients With ABI

November 1, 2024 updated by: Swiss Tropical & Public Health Institute

Long-term Effects on Socioemotional Skills of Animal-assisted Therapy in Patients With Acquired Brain Injury

The aim of this study is to investigate weather patients treated with animal-assisted therapy show better socioemotional skills compared to treatment as usual.

70 patients will be allocated randomly to one of two groups (control group and intervention group). During 6 weeks, all patients get two therapy sessions (AAT vs. TAU) per week. The 35 patients in the control group will get treatment as usual (TAU) in speech therapy, occupational therapy or physiotherapy twice a week whereas the 35 patients in the intervention group will get the same therapies but there will be an animal included in the therapy sessions.

The main outcome is the amount of expressed emotion and interaction in a standardized social situation measured via behavioral video coding.

Measurements will be done before the first therapy session (pre-measurement, t0) and after the last therapy session (post-measurement, t1) of the 6 weeks of intervention. The follow-up measurement will be done 6 weeks (follow-up I, t2) and 12 weeks later (follow-up II, t3).

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • BS
      • Basel, BS, Switzerland, 4055
        • REHAB Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Informed consent as documented signed by the patient or his/her legal representative
  • Inpatients of REHAB Basel with acquired brain injury and FIM-score over 60 (Funktionale Selbstständigkeitsmessung, Internationale Vereinigung für Assessment in der Rehabilitation, 1997)
  • Minimum age of 18 years

Exclusion Criteria:

  • Enrolment of the investigator, his/her family members, employees and other dependent persons
  • medical contraindications for contact with animals as allergy, phobia etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Animal-assisted therapy
The intervention is animal-assisted occupational therapy, animal-assisted physiotherapy or animal assisted speech therapy with different animals. All animals are trained for the specific service with vulnerable patients. There are guinea pigs, rabbits, miniature pigs, sheeps, goats, chicken, dogs, cats and horses.
Animal-assisted occupational therapy, animal-assisted physiotherapy and animal assisted speech therapy with different animals. All animals are trained for the specific service with vulnerable patients. There are guinea pigs, rabbits, miniature pigs, sheeps, goats, chicken, dogs, cats and horses.
Active Comparator: Treatment as usual (activation program)
As control intervention patients receive treatment as usual (TAU) in speech therapy, occupational therapy or physiotherapy. The control intervention is named activation program.
Speech therapy, occupational therapy or physiotherapy
Other Names:
  • activation program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
socioemotional behaviour
Time Frame: 18 weeks
The amount of expressed emotion andsocial interaction in a standardized social situation measured via behavioral video coding.
18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social cognition
Time Frame: 18 weeks

Measured via the "Movie for the Assessment of Social Cognition" MASC, Movie for the assessment of social cognition

The MASC is a video based test, where 46 questions need to be answered. Correct answer = 1 point, incorrect answer = 0 point. The more questions are answered correctly the merrier the results are.

Each question has four answer options. Each option has its own signification:

a) correct ToM, b) exceeding ToM, c) less ToM, d) no ToM

  1. Emotion: 17 items, total score range 0-17
  2. Intention: 18 items, total score range 0-18
  3. Thoughts: 7 items, total score range 0-7

Overall score range 0-46. The higher the score, the higher the capability of theory of mind (ToM).

There is a rage of 30-39 right answered questions in healthy populations.

18 weeks
Therapy motivation
Time Frame: 18 weeks

Measured with the questionnaire FPTM

FPTM: Fragebogen zur Erfassung der Psychotherapiemotivation.

Questionnaire measuring psychotherapy motivation with 39 items and 6 subscales:

  1. Physiological strain (Psychischer Ledensdruck): 10 itmens, total score range 10-40
  2. Hope for improvement (Hoffnung): 7 items, total score range 7-28
  3. Refuse of psychological need (Verneinung psychischer Hilfsbedürftigkeit): 7 items, score range 7-28
  4. Knowledge about treatment (Wissen): 5 items, total score range 5-20
  5. Initiative for treatment (Initiative): 4 items, total score range 4-16
  6. Symptom based care through others (Symptombezogene Zuwendung durch andere): 6 itmens, sore range 6-36

Each question needs to be ranged from 1 to 4, high number mean higher motivation:

  1. = don't agree at all
  2. = don't agree
  3. = agree
  4. = totally agree

Overall score range 39-156.

18 weeks
Quality of life score
Time Frame: 18 weeks

Measured via the WHOQL-BREF

WHOQL_BREF, World Health Organization Quality of Life

Questionnaire about quality of life with 26 questions and four subscales:

  1. Physical health (Physische Gesundheit): 7 items, total score range 7-35
  2. Psychological health (Psychologische Gesundheit): 6 items, total score range 6-30
  3. Social relationship (Soziale Beziheungen): 3 items, total score range 3-15
  4. Environment (Umwelt): 8 items, total score range 8-40

Each question needs to be ranged from 1 to 5, high number mean higher quality of life.

  1. = don't agree at all
  2. = don't agree
  3. = neutral
  4. = agree
  5. = totally agree

Overall score range 26-130.

18 weeks
Depression
Time Frame: 18 weeks

Measured via the BDI-FS

BDI-FS, Beck Depressions-Inventar Fast Screening Questionnaire with 7 questions about negative feelings who need to be ranged from 0-3. High number mean higher rates in depression.

0 = don't agree

  1. = agree little
  2. = agree
  3. = totally agree

Overall score range 0-21.

18 weeks
Adherence to treatnemt
Time Frame: 6 weeks
Percentage of completed therapy sessions
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

June 20, 2024

Study Completion (Actual)

June 20, 2024

Study Registration Dates

First Submitted

September 26, 2018

First Submitted That Met QC Criteria

September 26, 2018

First Posted (Actual)

September 27, 2018

Study Record Updates

Last Update Posted (Actual)

November 5, 2024

Last Update Submitted That Met QC Criteria

November 1, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acquired Brain Injury

Clinical Trials on Animal-assisted therapy

Subscribe